REG gamma: A potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 31-41

  Wang, Xiaoyi ^a   Tu, Shengfen ^a   Tan, Jinxiang ^a   Tian, Tian ^a   Ran, Liang ^a   Rodier, Jean Francois ^b   Ren, Guosheng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CENTRE PAUL STRAUSS   (France)

Author keywords

Breast cancer; Cell growth; CerBb 2; Estrogen receptor; Metastatic lymph nodes; REG

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROTEIN REG GAMMA; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; AUTOANTIGENS; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL CYCLE; CELL PROLIFERATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 79952243027     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-010-9546-8     Document Type: Article

References (33)

1. O Coux K Tanaka AL Goldberg 1996 Structure and functions of the 20S and 26S proteasomes Annu Rev Biochem 65 801 847 8811196 10.1146/annurev.bi.65. 070196.004101 1:CAS:528:DyaK28XktFamurc%3D (Pubitemid 26255262)
2. J Lowe D Stock B Jap P Zwickl, et al. 1995 Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution Science 268 533 539 7725097 10.1126/science.7725097 1:STN:280:DyaK2M3kt1Sqtw%3D%3D
3. K Ahn M Erlander D Leturcq PA Peterson, et al. 1996 In vivo characterization of the proteasome regulator PA28 J Biol Chem 271 18237 18242 8663520 10.1074/jbc.271.30.18100 1:CAS:528:DyaK28XksFyhtr8%3D (Pubitemid 26250798)
4. A Soza C Knuehl M Groettrup P Henklein, et al. 1997 Expression and subcellular localization of mouse 20S proteasome activator complex PA28 FEBS Lett 413 27 34 9287111 10.1016/S0014-5793(97)00864-8 1:CAS:528: DyaK2sXlt1Glt7g%3D (Pubitemid 27348631)
5. C Wojcik K Tanaka N Paweletz U Naab, et al. 1998 Proteasome activator (PA28) subunits, α, β and γ (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells Eur J Cell Biol 77 151 160 9840465 1:CAS:528:DyaK1cXntF2ksL4%3D (Pubitemid 28508597)
6. M Rechsteiner C Realini V Ustrell 2000 The proteasome activator 11S REG(PA28) and classIantigen presentation Biochem J 345 1 15 10600633 10.1042/0264-6021:3450001 1:CAS:528:DC%2BD3cXot1KntA%3D%3D (Pubitemid 30060098)
7. B Luscher RN Eisenman 1998 c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock Mol Cell Biol 8 2504 2512
8. C Salvat C Aquaviva I Jariel-Encontre, et al. 1999 Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Mol Biol Rep 26 45 51 10363646 10.1023/A:1006960021281 1:CAS:528:DyaK1MXjsVyltr0%3D (Pubitemid 29223250)
9. H He XM Qi J Grossmann, et al. 1998 c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis J Biol Chem 273 25015 25019 9737957 10.1074/jbc.273.39.25015 1:CAS:528:DyaK1cXmsVGmtrg%3D (Pubitemid 28443257)
10. M Glotzer AW Murry MW Kirschner 1991 Cyclin is degraded by the ubiquitin pathway Nature 349 132 138 1846030 10.1038/349132a0 1:CAS:528: DyaK3MXps12jtA%3D%3D (Pubitemid 21912025)
11. A Moro SE Perea C Pantoja, et al. 2001 IFNα2b induces apoptosis and proteasome-mediated degradation of p27Kip1 in a human lung cancer cell line Oncol Rep 8 425 429 11182068 1:CAS:528:DC%2BD3MXit1anu7k%3D (Pubitemid 33758106)
12. BM Machiels ME Henfling JL Broers, et al. 1995 Changes in immunocytochemical detectability of proteasome epitopes depending on cell growth and fixation conditions of lung cancer cell lines Eur J Cell Biol 66 282 292 7539747 1:CAS:528:DyaK2MXkvFyqu7g%3D
13. H Kanayama K Tanaka M Aki, et al. 1991 Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells Cancer Res 51 6677 6685 1660345 1:STN:280:DyaK38%2Fns1CjsQ%3D%3D
14. XM Fan BC Wong WP Wang, et al. 2001 Inhibition of proteasome function induced apoptosis in gastric cancer Int J Cancer 93 481 488 11477551 10.1002/ijc.1373 1:CAS:528:DC%2BD3MXlsVCntr0%3D (Pubitemid 32701406)
15. RJ Bold S Virudachalam DJ McConkey 2001 Chemosensitization of pancreatic cancer by inhibition of the 26s proteasome J Surg Res 100 11 17 11516199 10.1006/jsre.2001.6194 1:CAS:528:DC%2BD3MXmtVOnsbw%3D (Pubitemid 32802698)
16. T Tenev M Marani I McNeish, et al. 2001 Pro-caspase-3 overexpression sensitizes ovarian cancer cells to proteasome inhibitors Cell Death Differ 8 256 264 11319608 10.1038/sj.cdd.4400808 1:CAS:528:DC%2BD3MXjsVSgsbo%3D (Pubitemid 32288171)
17. A Kumatori K Tanaka N Inamura, et al. 1990 Abnormally high expression of proteasomes in human leukemic cells Proc Natl Acad Sci USA 87 7071 7075 2205851 10.1073/pnas.87.18.7071 1:CAS:528:DyaK3cXlvV2js70%3D
18. S Murata H Kawahara S Tohma, et al. 1999 Growth retardation in mice lacking the proteasome activator PA28γ J Biol Chem 274 38211 38215 10608895 10.1074/jbc.274.53.38211 1:CAS:528:DC%2BD3cXkt1GqsQ%3D%3D (Pubitemid 30026896)
19. M Malumbres M Barbacid 2001 To cycle or not to cycle: a critical decision in cancer Nat Rev Cancer 1 222 231 11902577 10.1038/35106065 1:CAS:528:DC%2BD38XlvF2qtrg%3D (Pubitemid 33741897)
20. CF Hung KC Lu TZ Cheng, et al. 2006 A novel siRNA validation system for functional screening and identification of effective RNAi probes in mammalian cells Biochem Biophys Res Commun 346 3 707 720 16793020 10.1016/j.bbrc.2006.05. 164 1:CAS:528:DC%2BD28XmtlWrsL8%3D
21. P Masson O Andersson UM Petersen, et al. 2001 Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGγ(PA28γ) J Biol Chem 276 1383 1390 11027688 10.1074/jbc.M007379200 1:CAS:528:DC%2BD3MXmtV2isw%3D%3D (Pubitemid 32096569)
22. X Gao J Li G Pratt, et al. 2004 Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma) Arch Biochem Biophys 425 158 164 15111123 10.1016/j.abb.2004.03.021 1:CAS:528:DC%2BD2cXjsVWms7g%3D (Pubitemid 38542807)
23. O Tomohisa T Shin-Ichi O Tsuyoshi, et al. 2003 Abnormally high expression of proteasome activator-γin Thyroid neoplasm J Clin Endocrinol Metab 88 1374 1383 10.1210/jc.2002-021413 (Pubitemid 36337803)
24. X Chen LF Barton Y Chi, et al. 2007 Ubiquitin-independent degradation of cell-cycle inhibitors by the REG gamma proteasome Mol Cell 26 843 852 17588519 10.1016/j.molcel.2007.05.022 1:CAS:528:DC%2BD2sXnsFSru7k%3D (Pubitemid 46921008)
25. T Yi JH Baek HJ Kim, et al. 2007 Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis Exp Mol Med 39 213 221 17464183 1:CAS:528:DC%2BD2sXltFarsLk%3D (Pubitemid 46683407)
26. CJ Lee HT Kim, et al. 2008 Ovarian expression of p53 and p21 apoptosis regulators in gamma-irradiated mice Mol Reprod Dev 75 383 391 17551976 10.1002/mrd.20761 1:CAS:528:DC%2BD1cXovVCquw%3D%3D
27. S Bianchi M Paglierani G Zampi, et al. 1993 Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients Cancer 72 120 125 8099532 10.1002/1097-0142(19930701)72:1<120::AID- CNCR2820720123>3.0.CO;2-8 1:STN:280:DyaK3s3osVGlsg%3D%3D (Pubitemid 23182060)
28. GM Clark GW Sledge CK Osborne, et al. 1987 Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients J Clin Oncol 5 55 61 3806159 1:STN:280:DyaL2s7htFKrtA%3D%3D (Pubitemid 17007856)
29. DA Thompson RJ Weigel 1998 Characterization of a gene that is inversely correlated with oestrogen receptor expression (ICERE-1) in breast carcinomas Eur J Biochem 252 169 177 9523727 10.1046/j.1432-1327.1998.2520169.x 1:CAS:528:DyaK1cXhtlehurw%3D (Pubitemid 28089973)
30. N Platet C Prevostel D Derocq, et al. 1998 Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in oestrogen receptor-positive and -negative cells Int J Cancer 75 750 756 9495244 10.1002/(SICI)1097-0215(19980302)75:5<750:: AID-IJC14>3.0.CO;2-A 1:CAS:528:DyaK1cXhsVynu7w%3D (Pubitemid 28145823)
31. E Pluciennik R Kusinska P Potemski, et al. 2006 WWOX-the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis Eur J Surg Oncol 32 153 157 16360296 10.1016/j.ejso.2005.11.002 1:STN:280: DC%2BD287gtlCjtA%3D%3D (Pubitemid 43257115)
32. E Tagliabue S Menard JF Robertson, et al. 1999 c-erbB-2 expression in primary breast cancer Int J Biol Markers 14 16 26 10367245 1:STN:280: DyaK1M3psFehsw%3D%3D (Pubitemid 29237571)
33. J Shunqian Z Qimin 2002 Oncomolecularbiology is the forefront of basic medical research World Chin J Dig 10 678 680